X4 PHARMACEUTICALS INC shareholders Q3 2023

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.

X4 PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 6,247,500$6,809,7752.18%
Bain Capital Life Sciences Investors, LLC 15,960,588$17,397,0411.94%
Stonepine Capital Management, LLC 5,273,685$5,748,3171.91%
NEA Management Company, LLC 14,986,793$16,335,6041.26%
Sio Capital Management, LLC 2,599,003$2,832,9130.88%
New Leaf Venture Partners, L.L.C. 335,000$365,1500.47%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,973,683$2,151,3140.25%
Monashee Investment Management LLC 427,265$465,7190.20%
Orbimed Advisors 7,133,515$7,775,5310.16%
Parkman Healthcare Partners LLC 800,000$872,0000.16%
Perceptive Advisors 3,545,454$3,864,5450.13%
Polar Capital Holdings Plc 7,500,000$8,175,0000.06%
GSA CAPITAL PARTNERS LLP 621,587$6780.06%
Simplify Asset Management Inc. 400,000$436,0000.05%
UBS OCONNOR LLC 1,559,986$1,700,3850.04%
ARMISTICE CAPITAL, LLC 2,356,000$2,568,0400.04%
1620 INVESTMENT ADVISORS, INC. 10,000$10,9000.01%
AXA S.A. 3,147,865$3,431,1730.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,276,315$4,661,1830.01%
Total Clarity Wealth Management, Inc. 11,532$12,5700.01%
External links

This page lists X4 PHARMACEUTICALS INC's shareholders in Q3 2023. To view X4 PHARMACEUTICALS INC's shareholder history, click here.